Stem Cell Stocks 4/19/09: The Week That Was

Once again nothing definitive this week for the stem cell stocks. Most the the larger cap stock were up, but most of the smaller cap stocks fell for the week. I am really not expecting much from the stem cells stocks in the very near future. With the news from Dendreon last week, cancer related biotech stocks have become the new hot play. Unless some fresh big news develops in the stem cell space, look for the current trading action to continue.

Top Stem Cell Stock Performer(s) for Last Week:

- ThermoGenesis (KOOL) = Up 19% for the week; The only real news this week was that they appointed a new CEO; I don't think that is enough to maintain this momentum

Worst Stem Cell Stock Performer(s) for Last Week:

- International Stem Cell Corp (ISCO.OB) = Down -14% for the week; No news; A couple of weeks ago this had one of the best charts in the sector. It has significantly brokend down since then

Stem Cell Stocks Current Price and % Up or Down 4/13/09 - 4/17/09

Market Cap Over 50 Million

Ariad Pharmaceuticals (ARIA) = Current Price: $1.48; Up 3%
Aastrom Biosciences (ASTM) = Current Price: $0.354; Up 4%
BioTime, Inc. (BTIM) = Current Price: $1.75; Down -9%
Celgene Corp (CELG) = Current Price: $38.30; Down -6%
Cytori Therapeutics (CYTX) = Current Price: $1.81; Up 5%
Geron Corp (GERN) = Current Price: $5.40; Up 10%
ThermoGenesis (KOOL) = Current Price: $0.615; Up 19%
Osiris Therapeutics (OSIR) = Current Price: $12.82; Up 3%
StemCell Inc. (STEM) = Current Price: $1.69; Up 8%

Market Cap Under 50 Million

Advanced Cell Technology (ACTC.OB) = Current Price: $0.0995; Up 2%
Athersys Inc. (ATHX) = Current Price: $0.81; Down -4%
Brainstorm Cell Therapeutics (BCLI.OB) = Current Price: $0.08; Down -10%
Bioheart Inc. (BHRT) = Current Price: Current Price: $0.69; Up 1%
Cord Blood America Inc. (CBAI.OB) = Current Price: $0.0057; Unchanged
Cyro-Cell Intl (CCEL.OB) = Current Price: $0.70; Unchanged
Neuralstem (CUR) = Current Price: $1.20; Down -2%
International Stem Cell (ISCO.OB) = CurrentPrice: $0.43; Down -14%
LifeStem International (LSTM.OB) = Current Price: $0.009; Down -2%
MultiCell Technologies (MCET.OB) = Current Price: $0.0105; Down -10%
Pluristem Therapeutics (PSTI) = Current Price: $1.33; Up 8%
Stem Cell Therapy Intl (SCII.OB) = Current Price: $0.10; Unchanged
Stem Cell Innovations (SCLL.PK) = Current Price: $0.04; Down -13%

Catalyst(s) for the Week:

The catalyst(s) for the week remain unchanged from last week.

- Again, be on the lookout for further legislative movement to support President Obama's executive order.

- More Mutual fund distribution of funds originally allocated for Genentech. It will take quite a while to redistribute these dollars throughout the biotech sector

- M&A (mergers and acquisitions) activity will be key. It could happen at any time.

While the stem cell stocks lag, don't forget to check out my other blog which provides some insight on ways to make some quick money in the stock market.

No comments:

Post a Comment